Dilafor

Sweden
Solna, Stockholm, Sweden, 171 65

Company profile

Dilafor company profile

Dilafor AB is a Swedish drug development company focusing on the development of tafoxiparin for obstetric indications. The company’s primary goal is to decrease the incidence of slow progress of labor both after induction of labor and after spontaneous onset of labor.

Business identity

Contact email
[email protected]
Phone number
+46 70 790 02 07
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2003-01-01, Year

Headquarters

Postal code
171 65
Country code
SE
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Total equity funding
$5.9M
Last funding
Series Unknown / $5.9M / 2016-09-27
Last equity funding
Series Unknown / $5.9M
Investors
3
Lead investors
1
Founders
3
Articles
16

Founders and investors

Founders

Erik HolmerKjell GunnarssonPer-Olov Eriksson

Lead investors

Rosetta Capital

Investors

OstersjöstiftelsenPraktikerinvestRosetta Capital